Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Propel Drug-Eluting Sinus Implant Family IBUKI Cohort

NCT07546682 is registered in ClinicalTrials.gov with Medtronic as lead sponsor.

NCT NCT07546682
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07546682 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Propel Drug-Eluting Sinus Implant Family IBUKI Cohort
Lead sponsor
Medtronic
Phase
Observational
Overall status
Recruiting
Start date
April 30, 2026
Completion date
August 31, 2027
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic rhinosinusitis (crs)